Cordis Wins FDA Approval for SELUTION SLR Balloon
Miami Lakes, Florida, U.S., September 21, 2026 Cordis has announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Miami Lakes, Florida, U.S., September 21, 2026 Cordis has announced that the U.S. Food and Drug Administration (FDA) has...
Tel Aviv, Israel, September 9, 2026 AEYE announced publication of clinical-trial findings evaluating AEYE-DS, an autonomous artificial intelligence-based screening...
San Jose, California, September 9, 2026 Emboline has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
Shanghai, China, September 3, 2026 Pulnovo Medical announced clinical results from the PADN-HF-PH randomized controlled trial, evaluating pulmonary artery...
Chicago, Ill. – August 28, 2026 GE HealthCare announced three additions to its Vivid™ cardiovascular ultrasound portfolio — Vivid...
TORONTO, July 8, 2026 Conavi Medical Corp. announced the publication of a clinical case report in the Journal of...
ST. LOUIS and ROUEN, France, July 9, 2026 Stereotaxis announced the successful completion of its previously announced acquisition of...
ATLANTA, July 7, 2026 Nyra Medical, Inc. has announced the enrollment of the first patient in its ENHANCE Early...
MINNEAPOLIS, Minn., June 29, 2026 Laplace Interventional has reached a significant regulatory milestone after receiving U.S. Food and Drug...
MELBOURNE, Australia, June 29, 2026 4DMedical has achieved a major regulatory milestone with the Therapeutic Goods Administration (TGA) approving...
